- Home
- HURN vs RXRX Comparison
HURN vs RXRX Comparison
Compare HURN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURN
- RXRX
- Stock Information
- Founded
- HURN 2002
- RXRX 2013
- Country
- HURN United States
- RXRX United States
- Employees
- HURN N/A
- RXRX N/A
- Industry
- HURN Professional Services
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- HURN Consumer Discretionary
- RXRX Health Care
- Exchange
- HURN Nasdaq
- RXRX Nasdaq
- Market Cap
- HURN 2.3B
- RXRX 2.4B
- IPO Year
- HURN 2004
- RXRX 2021
- Fundamental
- Price
- HURN $138.73
- RXRX $4.94
- Analyst Decision
- HURN Strong Buy
- RXRX Buy
- Analyst Count
- HURN 4
- RXRX 5
- Target Price
- HURN $171.50
- RXRX $7.00
- AVG Volume (30 Days)
- HURN 199.0K
- RXRX 19.6M
- Earning Date
- HURN 07-31-2025
- RXRX 08-05-2025
- Dividend Yield
- HURN N/A
- RXRX N/A
- EPS Growth
- HURN 37.96
- RXRX N/A
- EPS
- HURN 5.74
- RXRX N/A
- Revenue
- HURN $1,556,665,000.00
- RXRX $64,596,000.00
- Revenue This Year
- HURN $11.50
- RXRX $19.96
- Revenue Next Year
- HURN $7.48
- RXRX $61.39
- P/E Ratio
- HURN $23.58
- RXRX N/A
- Revenue Growth
- HURN 9.24
- RXRX 30.14
- 52 Week Low
- HURN $102.58
- RXRX $3.79
- 52 Week High
- HURN $155.00
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- HURN 60.51
- RXRX 39.76
- Support Level
- HURN $134.94
- RXRX $4.72
- Resistance Level
- HURN $136.99
- RXRX $5.84
- Average True Range (ATR)
- HURN 3.42
- RXRX 0.31
- MACD
- HURN 0.89
- RXRX -0.11
- Stochastic Oscillator
- HURN 98.11
- RXRX 17.74
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.